Viewing Study NCT00702403


Ignite Creation Date: 2025-12-24 @ 7:38 PM
Ignite Modification Date: 2025-12-28 @ 7:49 PM
Study NCT ID: NCT00702403
Status: COMPLETED
Last Update Posted: 2017-08-10
First Post: 2008-06-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML
Sponsor: Fred Hutchinson Cancer Center
Organization: